Method for preparing pregabalin

Patent metadata

Field	Value
Publication number	US-11919835-B2
Application number	US-202017112917-A
Country	US
Kind code	B2
Filing date	Dec 4, 2020
Priority date	Jun 6, 2018
Publication date	Mar 5, 2024
Grant date	Mar 5, 2024

Abstract

The present invention relates to a method for preparing pregabalin by a biological enzyme method. In particular, the method comprises producing pregabalin B and an R-configuration compound C by using a compound A as a raw material under the action of a biological enzyme; performing configuration inversion of the separated and recovered R-configuration compound C under the action of an isomerase to produce an S-configuration compound D; and producing pregabalin B from the compound D under the action of a biological enzyme.

First claim

The invention claimed is:

1. A method for preparing pregabalin comprising:
reacting a compound of formula (I) in a first solvent with a biological enzyme to produce a target compound of formula (III) and a by-product of formula (II);
reacting the by-product of formula (II) in a second solvent with an isomerase to perform a configuration inversion to produce a compound of formula (IV);
reacting the compound of formula (IV) in a third solvent with the biological enzyme to produce the target compound of formula (III);

wherein:
R 1 and R 2 are independently hydrogen or an alkyl group; and
the biological enzyme is a hydrolase.

2. The method of claim 1 , wherein the hydrolase is a lipase.

3. The method of claim 2 , wherein the lipase is a mold lipase, a yeast lipase, or a bacterial lipase.

4. The method of claim 3 , wherein the mold lipase is from a Rhizopus delemar , an Aspergillus niger , a Rhizomucor miehei , or a Gertrichum candidum.

5. The method of claim 3 , wherein the yeast lipase is from Candida antarctica B, Candida cylindracea , or Rhodoaorula glutinis.

6. The method of claim 3 , wherein the bacterial lipase is from Burkholderia cepacia, Pseudomonas , or Staphylococcus epidermidis.

7. The method of claim 1 , wherein the isomerase is an epimerase.

8. The method of claim 7 , wherein the epimerase is selected from the group consisting of glucose isomerase, sucrose isomerase, D-tagatose 3-epimerase, D-psicose 3-epimerase, cellobiose 2-epimerase and 2-ketogluconate epimerase.

9. The method of claim 1 , wherein the biological enzyme, the isomerase, or both are in the form of immobilized enzyme particles, enzyme powder, or cells or organelles containing the biological enzyme or the isomerase.

10. The method of claim 1 , wherein R 1 and R 2 are independently a C 1 -C 4 branched or straight chain alkyl group.

11. The method of claim 1 , wherein R 1 is H and R 2 is methyl.

12. The method of claim 1 , wherein
the biological enzyme and the compound of formula (I) have a mass ratio of 1:2-1:20; and/or
the isomerase and the compound of formula (II) have a mass ratio of 1:1-1:20; and/or
the biological enzyme and the compound of formula (IV) have a mass ratio of 1:2-1:20.

13. The method of claim 1 , wherein the first solvent and the third solvent is water or a miscible system of water and an organic solvent.

14. The method of claim 1 , wherein the mass-volume ratio of the compound of formula (I) to the first solvent or the compound of formula (IV) to the third solvent is 1 g:10 mL-1 g:50 mL.

15. The method of claim 1 , wherein the second solvent is an organic solvent.

16. The method of claim 1 , wherein the mass-volume ratio of the compound of formula (II) to the second solvent is 1 g:10 mL-1 g:50 mL.

17. The method of claim 1 , wherein the reacting a compound of formula (I), the reacting the by-product of formula (II), and/or the reacting the compound of formula (IV) is at a temperature range from 25° C. to 55° C.

18. The method of claim 1 , wherein the reacting a compound of formula (I), the reacting the by-product of formula (II), and/or the reacting the compound of formula (IV) is for a time from 5 h to 20 h.

19. The method of claim 1 further comprising extracting the by-product of formula (II) before the reacting with the isomerase.

20. The method of claim 19 , wherein the extracting is with a fourth organic solvent selected from the group consisting of toluene, dichloromethane, methyl tert-butyl ether, and ethyl acetate.

Assignees

• Zhejiang Huahai Pharm Co Ltd

Inventors

• Yang Changming
• Guo Pan
• Wang Yifeng
• Zhang Wenling
• Wang Peng

Classifications

• C07C229/08 Primary

  the nitrogen atom of the amino group being further bound to hydrogen atoms · CPC title

• C12N9/60

  from yeast · CPC title

• C12N9/90 Primary

  Isomerases (5.) · CPC title

• C07D207/267

  with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom · CPC title

• C07C227/30

  Preparation of optical isomers · CPC title